|
|
|
|
| LEADER |
02768nam a22003135i 4500 |
| 001 |
000287726 |
| 005 |
20200921101833.0 |
| 007 |
cr nn 008mamaa |
| 008 |
190904s2020 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493997947
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-9794-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Oncolytic Viruses /
|c edited by Christine E. Engeland.
|
| 250 |
|
|
|a 1st ed. 2020.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Humana,
|c 2020.
|
| 300 |
|
|
|a XI, 329 p. 64 illus., 48 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 2058
|
| 505 |
0 |
|
|a Introduction to Oncolytic Virotherapy -- Methods for Modification of Therapeutic Viruses -- Tumor Targeting of Oncolytic Adenoviruses using Bispecific Adapter Proteins -- Development of Entry-targeted Oncolytic Measles Viruses -- Insert Stability and In Vivo Testing of MicroRNA-Detargeted Oncolytic Picornaviruses -- Ex vivo Virotherapy with Myxoma Virus to Treat Cancer -- Immunomodulation in Oncolytic Measles Virotherapy -- A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death -- Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation -- Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue -- Immunohistochemistry for Tumor-infiltrating Immune Cells after Oncolytic Virotherapy -- Detection of Tumor Antigen-specific T-cell Responses after Oncolytic Vaccination -- Evaluation of Oncolytic Virus Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models -- Delivery of Oncolytic Reovirus by Cell Carriers -- In Vivo Bioimaging for Monitoring Intratumoral Virus Activity -- Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 virus: Using a Bladder Tumour Precision-cut Slice Model System to Assess Viral Efficacy -- Use of Liquid Patient Ascites Fluids as a Pre-clinical Model for Oncolytic Virus Activity -- Generating Primary Models of Human Cancer to Aid in the Development of Clinically-relevant Oncolytic Viruses -- Considerations for Clinical Translation of MG1 Maraba Virus -- Fluorescence in Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-treated Human Brain Tumors -- Mathematical Modeling of Oncolytic Virotherapy. .
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Virology.
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Virology.
|
| 700 |
1 |
|
|a Engeland, Christine E.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|